Table S4.
Subject demographic and clinical information of the independent sample
| Demographic | BD | HC | |||
| BD TOT | Manic BD | Depressed BD | Euthymic BD | ||
| Sample size n (%) | 23 (100) | 8 (34.7) | 9 (39.1) | 6 (26) | 18 (100) |
| Age mean (SD) | 46.8 (8.6) | 47.8 (8.8) | 43.6 (8.0) | 50.1 (8.9) | 29.6 (5.4) |
| Female n (%) | 14 (60.8) | 4 (50) | 5 (55.5) | 5 (83.3) | 12 (66.6) |
| Age of onset mean (SD) | 30.7 (7.8) | 29.1 (8.5) | 31.8 (7.8) | 31.1 (8.0) | — |
| Duration of illness mean (SD) | 16.9 (13.0) | 18.7 (15.2) | 11.7 (9.9) | 19.0 (14.4) | — |
| HAM-D mean (SD) | — | 3.5 (2.6) | 21.6 (3.1) | 2.0 (2.4) | — |
| YMRS mean (SD) | — | 19.1 (4.4) | 3.3 (3.0) | 0.5 (0.8) | — |
| Mood stabilizers n (%) | 20 (86.9) | 8 (100) | 7 (77.7) | 5 (83.3) | — |
| Lithium n (%) | 6 (26) | 2 (25) | 1 (11.1) | 3 (50) | — |
| Valproate n (%) | 13 (56.5) | 6 (75) | 5 (55.5) | 2 (33.3) | — |
| Other antiepileptic drugs n (%) | 2 (8.6) | 0 (0) | 2 (22.2) | 0 (0) | — |
| Antidepressants n (%) | 8 (34.7) | 0 (0) | 5 (55.5) | 3 (50) | — |
| SRI n (%) | 6 (26) | 0 (0) | 4 (44.4) | 2 (33.3) | — |
| Tricyclic antidepressants n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — |
| Duals and other antidepressants n (%) | 3 (13) | 0 (0) | 1 (11.1) | 2 (33.3) | — |
| Antipsychotics n (%) | 14 (60.8) | 5 (62.5) | 7 (77.7) | 2 (33.3) | — |
| Atypical n (%) | 11 (47.8) | 3 (37.5) | 6 (66.6) | 2 (33.3) | — |
| Typical n (%) | 3 (13) | 2 (25) | 1 (11.1) | 0 (0) | — |
| Benzodiazepines n (%) | 6 (26) | 2 (25) | 3 (33.3) | 1 (16.6) | — |
| Unmedicated n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | — |
SRI, serotonin reuptake inhibitors.